Consumers say they will report serious side effects to the FDA if toll free numbers and Web site information are included in TV ads.
A new MedWatch, Consumers Union gave the FDA a petition signed by nearly 56,000 consumers asking that a toll-free number and Web site be included in all TV drug ads so they can easily report their serious side effects to the agency.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.